Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Layale Yaghi, Isabelle Poras, Renata T. Simoes, Eduardo A. Donadi, Jörg Tost, Antoine Daunay, Bibiana Sgorla de Almeida, Edgardo D. Carosella, Philippe Moreau
Published Aug 26, 2016 · Vol. 7, No. 39 · pp. 63690-63707
Allison Eberhardt, Jeanne N. Hansen, Jan Koster, Louis T. Lotta Jr, Simeng Wang, Emmett Livingstone, Kun Qian, Linda J. Valentijn, Yujun George Zheng, Nina F. Schor, Xingguo Li
Published Aug 23, 2016 · Vol. 7, No. 39 · pp. 63629-63639
Marta Hegyi, Adam Arany, Agnes F. Semsei, Katalin Csordas, Oliver Eipel, Andras Gezsi, Nora Kutszegi, Monika Csoka, Judit Muller, Daniel J. Erdelyi, Peter Antal, Csaba Szalai, Gabor T. Kovacs
Published Aug 23, 2016 · Vol. 8, No. 6 · pp. 9388-9398